Amersham picks CPR for proactive European PR work

Bio-tech giant Amersham Biosciences has hired CPR Worldwide for pan-European product PR work.

CPR was chosen last week after a five-way pitch, and is set to start work in March.

Amersham Biosciences global product PR manager Helen Petts said the company - which develops equipment for disease research and drug development - had not pursued 'proactive' product PR in Europe 'for a couple of years'.

CPR will work across Amersham Biosciences' five business areas: genomics, proteomics, bioassays, protein separations and informatics.

The agency will promote products such as the IN Cell Analyzer 3000, a sensitive imaging tool that uses a laser-based microscope system to osberve a drug compound entering a cell and the biological changes that occur in response to the drug.

Petts said CPR would target the bio-tech trade press, concentrating on western Europe and Scandinavia, to raise awareness.

Petts, who reports to Sweden-based V-P of brand comms Catarina Tagmark-Olaisson, joined Amersham in a newly created position in September last year, from a role as European PR manager for Cadence Design Systems.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.